Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01873911 : Neurobehavioral Phenotypes in MPS III
PhaseN/A
AgesMin: 2 Years Max: 12 Years
Eligibility
Inclusion Criteria:

Research Subjects: Verified diagnosis of MPS IIIA or MPS IIIB (having proof of either
genetic mutation or enzymatic analysis prior to enrollment in this study); must be between
the ages of 2 and 12 years; must be able to walk.

Control group: Verified diagnosis of MPS IH; must have already undergone hematopoietic
cell transplantation in the past; must be aged between 2 and 5 years; and must be able to
walk without support.

Exclusion Criteria:

Participants will be excluded who are unable to cooperate or comply with this study's
procedures; in the opinion of the principal investigator, participants who have other
severely-limiting co-existing conditions such as severe hearing or visual impairment, will
be excluded from this study.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01873911      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740